Oscar Health (OSCR) Jumps 7.8% on New Menopause Plan, AI Tools

We recently published 10 Stocks Leaving Wall Street in the Dust. Oscar Health Inc. (NYSE:OSCR) is one of the best performers on Tuesday.

Oscar Health grew for a second day on Tuesday, adding 7.88 percent to end at $21.77 apiece as investors welcomed its launch of a new menopause health plan and AI tools to support its customers and medical practitioners.

In a statement, Oscar Health Inc. (NYSE:OSCR) said it partnered with Elektra Health, a leading virtual menopause care provider, for the launch of HelloMeno, a new insurance product aimed at helping 2.3 million women over 45 years old take control of perimenopause and menopause.

Priced $900 annually, the new product would cover free consultations, behavioral visits, laboratory tests, and medications, among others.

Additionally, Oscar Health Inc. (NYSE:OSCR) announced a new AI agent called Oswell to provide on-demand support to doctors and members.

Oscar Health Inc. (NYSE:OSCR) said Oswell is capable of pulling data from medical records and plan benefit documents to help members understand medications, explain common test results, check drug interactions, get prescription refills, review symptoms, and provide questions to ask their doctors, among others.

While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.